AHCO:NSD-AdaptHealth Corp (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 19.12

Change

-0.43 (-2.20)%

Market Cap

USD 2.71B

Volume

0.80M

Avg Analyst Target

USD 31.67 (+65.62%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AdaptHealth Corp (AHCO) Stock Analysis:
Based on the AdaptHealth Corp stock forecasts from 2 analysts, the average analyst target price for AdaptHealth Corp is USD 31.67 over the next 12 months. AdaptHealth Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AdaptHealth Corp is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, AdaptHealth Corp’s stock price was USD 19.12. AdaptHealth Corp’s stock price has changed by -3.03% over the past week, -2.23% over the past month and -49.55% over the last year.

About

AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individua ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-19 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM DexCom Inc

+5.36 (+1.25%)

USD43.36B 84.37 117.62
ALGN Align Technology Inc

+8.03 (+1.64%)

USD41.37B 56.55 48.05
PODD Insulet Corporation

+0.92 (+0.39%)

USD16.15B 2,208.27 199.97
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
ABMD Abiomed Inc

+9.64 (+3.30%)

USD13.70B 92.48 46.15
BRKR Bruker Corporation

+0.08 (+0.12%)

USD10.73B 39.93 25.78
TNDM Tandem Diabetes Care Inc

+7.60 (+6.54%)

USD7.67B 356.22 187.52
SWAV ShockWave Medical Inc

-11.24 (-7.20%)

USD5.90B N/A N/A
IART Integra LifeSciences Holdings ..

-0.23 (-0.34%)

USD5.83B 27.08 17.89
LIVN LivaNova PLC

-0.53 (-0.63%)

USD4.51B 77.40 N/A

ETFs Containing AHCO

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.83% 16% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.83% 16% F 13% F
Trailing 12 Months  
Capital Gain -49.55% 36% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -49.55% 36% F 23% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 39.01% 63% D 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.01% 63% D 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 76.89% 38% F 21% F
Risk Adjusted Return 50.73% 73% C 70% C-
Market Capitalization 2.71B 88% B+ 80% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio -99,999.99 94% A 99% A+
Price/Book Ratio 1.45 84% B 68% D+
Price / Cash Flow Ratio 13.85 23% F 29% F
EV/EBITDA 10.19 71% C- 61% D-
Management Effectiveness  
Return on Equity 3.63% 77% C+ 56% F
Return on Invested Capital 10.51% 86% B 78% C+
Return on Assets 4.39% 88% B+ 76% C
Debt to Equity Ratio 185.63% 12% F 10% F
Technical Ratios  
Short Ratio 8.17 11% F 8% F
Short Percent 8.57% 13% F 20% F
Beta 0.14 89% B+ 92% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative earnings

The company had negative total earnings in the most recent four quarters.